| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 11 |
| 1 | CYCLOPHOSPHAMIDE | 10 |
| 2 | CYCLOPHOSPHAMIDE FOR INJECTION | 10 |
| 3 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 10 |
| 4 | RITUXIMAB | 10 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 10 |
| 6 | TACROLIMUS OINTMENT 0.1% | 10 |
| 7 | METHYLPREDNISOLONE | 9 |
| 8 | PREDNISONE | 9 |
| 9 | PREDNISOLONE | 8 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SEVELAMER HYDROCHLORIDE | 1 | 0.0017 |
| 1 | ZILEUTON | 1 | 0.0015 |
| 2 | TREOSULFAN | 2 | 0.0007 |
| 3 | SODIUM POLYSTYRENE SULFONATE | 1 | 0.0006 |
| 4 | OMAVELOXOLONE | 1 | 0.0006 |
| 5 | (DAUNORUBICIN AND CYTARABINE) LIPOSOME | 1 | 0.0004 |
| 6 | DEFLAZACORT | 1 | 0.0004 |
| 7 | TOFACITINIB CITRATE | 5 | 0.0004 |
| 8 | AMPHOTERICIN B | 4 | 0.0003 |
| 9 | LEVOCARNITINE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | 5-Lipoxygenase Inhibitor [EPC] | 1 | 0.0015 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 4 | 0.0003 |
| 3 | Carnitine Analog [EPC] | 1 | 0.0003 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 5 | 0.0002 |
| 5 | GLP-2 Analog [EPC] | 2 | 0.0001 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 3 | 0.0001 |
| 7 | Polyene Antifungal [EPC] | 5 | 0.0001 |
| 8 | Vitamin K [EPC] | 1 | 0.0001 |
| 9 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |